Close Menu

More articles about Point-of-Care Testing

The researchers believe that their prototype could be the basis of a portable, point-of-care testing platform that would enable rapid testing anywhere.

The firm is developing a test to determine interleukin-6 levels for SARS-CoV-2 patients and a rapid antigen test.

Under the emergency use authorization, the rapid antigen test can be used in both symptomatic and asymptomatic individuals, and in children as well as adults.

The firm said that the National Institute for Health and Care Excellence has selected its EarlyCDT Lung test for its Diagnostics Assessment Guidance.

The organization intends to deploy a prototype of the platform in Brussels Airport next summer.

Epoc NXS Host with the Epoc Blood Analysis System provides color-coded test results quickly and simplifies and streamlines the blood gas testing process.

Kenota's point-of-care test takes less than 30 minutes and can detect allergies from a finger prick of blood sample.

The iQ Group Global is integrating the Wyss Institute's technology with its own organic thin-film biosensor platform for SARS-CoV-2 serology testing. 

The firm said its test fits in the palm of a hand and delivers results in 30 minutes by detecting bacterial nucleic acid in throat, nasal, or nasopharyngeal swabs.

The company received $26.1 million from the National Institutes of Health and the Biomedical Advanced Research and Development Authority to develop the test.

The German startup said its CE-marked, clinically validated OsteoTest detects osteoporosis and can be used to monitor therapy.

The Cellex qSARS-COV-2 Antigen Rapid Test includes a disposable rapid antigen testing lateral flow device to detect active SARS-CoV-2 infection.

The 20-minute PCR-based test had near complete agreement with lab-based testing.

The GeneMe assay, called FRANKD, is currently being used to test Virgin Atlantic pilots and crew of certain routes departing Heathrow Airport.

Some insiders emphasize the importance of doing rapid turnaround testing of asymptomatic people, while others contend lab tests ought to be the modality of choice.

The firm said that part of the funding will support the development of a rapid, multiplex DPP Respiratory Antigen Panel for the upcoming flu season.

Wyss Institute said iQ Group Global will integrate its affinity-based technology with a biosensor platform that includes organic thin-film transistors to enhance electrical signals.

The firms said that their hand-held digital test would require minimal training and be performed at the point of care without the need of a laboratory.

The German biotech firm said its lateral flow blood test does not detect subclinical HPV infection but picks up on HPV-induced cancers and pre-cancers.

The loop-mediated isothermal amplification test runs on a battery-powered device to provide self-testing individuals with results in approximately 30 minutes.